{
    "organizations": [],
    "uuid": "8f3d5e38d8cc80620eacf8e713cc1e34e37d0b75",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eyegene-receives-patent/brief-eyegene-receives-patent-idUSL3N1PB2U1",
    "ord_in_thread": 0,
    "title": "BRIEF-EyeGene receives patent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 16 (Reuters) - EyeGene Inc :\n* Says it received patent on Jan. 15, for vaccine for inducing an improved immune reaction\n* Patent number is 10-2014-7010000\nSource text in Korean: goo.gl/qcYcuV\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-16T16:00:00.000+02:00",
    "crawled": "2018-01-17T19:52:41.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "eyegene",
        "inc",
        "say",
        "received",
        "patent",
        "vaccine",
        "inducing",
        "improved",
        "immune",
        "reaction",
        "patent",
        "number",
        "source",
        "text",
        "korean",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}